Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 12Central Nervous System Neoplasms 11Brain Neoplasms 9Astrocytoma 8Glioma 6Oligodendroglioma 4Gliosarcoma 3Neoplasms 2Medulloblastoma 2Leukemia, Myeloid, Acute 2Spinal Cord Neoplasms 1Optic Nerve Glioma 1Neoplasms, Plasma Cell 1Neoplasm Recurrence, Local 1Multiple Myeloma 1Cognition Disorders 1

Interventions

Vincristine 4Platinum 4Cyclophosphamide 4Cisplatin 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy 3Radiation 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3sodium thiosulfate 2Specimen Handling 2Metformin 2Magnetic Resonance Spectroscopy 2Lomustine 2Carboplatin 2merphos 1Thiotepa 1Tablets 1Stem Cell Transplantation 1Spinal Puncture 1Restraint, Physical 1Methotrexate 1Leucovorin 1Isotretinoin 1Hearing 1Fentanyl 1Evoked Potentials, Auditory, Brain Stem 1Etoposide 1Donepezil 1Cyproheptadine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Medulloblastoma × Lomustine × Clear all
NCT05382338 2026-05-05

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Oncology Group

Phase 3 Recruiting
225 enrolled
CNS

Medulloblastoma

NCT00085735 2025-01-14

Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma

Children's Oncology Group

Phase 3 Completed
549 enrolled 32 charts
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡